Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023269350> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2023269350 endingPage "599" @default.
- W2023269350 startingPage "593" @default.
- W2023269350 abstract "Ber-EP4 is a recently characterized monoclonal antibody directed against a cell surface glycoprotein that is putatively present on human epithelial cells but lacking on the mesothelium. To investigate the diagnostic efficacy of Ber-EP4 in distinguishing adenocarcinoma from mesothelioma, we studied formalin-fixed, paraffin-embedded sections from well-documented cases of adenocarcinoma (120 cases), adenomatoid tumor (nine cases), and malignant mesothelioma (49 cases). Of the 120 adenocarcinomas, 103 (86%) showed membranous Ber-EP4 positivity, with diffuse reactivity noted in 82 cases and focal staining in 21 cases. Reactivity with Ber-EP4 was also observed in two of nine adenomatoid tumors (22%) and 10 of 49 mesotheliomas (20%). Staining in the mesotheliomas was restricted to epithelioid areas and generally focal. In one mesothelioma, however, Ber-EP4 stained the majority of neoplastic cells. In contrast to previous reports, we conclude that positivity with Ber-EP4 does not exclude the diagnosis of mesothelioma. Nonetheless, most Ber-EP4-positive mesotheliomas exhibit only focal positivity, as opposed to the extensive staining commonly observed in adenocarcinomas. Ber-EP4 has diagnostic utility in the discrimination of mesothelioma from adenocarcinoma, but it is best utilized in an antibody panel that includes other markers of carcinomatous differentiation." @default.
- W2023269350 created "2016-06-24" @default.
- W2023269350 creator A5031094606 @default.
- W2023269350 creator A5050821841 @default.
- W2023269350 creator A5055065582 @default.
- W2023269350 creator A5058317335 @default.
- W2023269350 creator A5068113028 @default.
- W2023269350 creator A5076715600 @default.
- W2023269350 date "1992-06-01" @default.
- W2023269350 modified "2023-09-26" @default.
- W2023269350 title "Immunoreactivity for BER-EP4 in Adenocarcinomas, Adenomatoid Tumors, and Malignant Mesotheliomas" @default.
- W2023269350 doi "https://doi.org/10.1097/00000478-199206000-00007" @default.
- W2023269350 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1599037" @default.
- W2023269350 hasPublicationYear "1992" @default.
- W2023269350 type Work @default.
- W2023269350 sameAs 2023269350 @default.
- W2023269350 citedByCount "115" @default.
- W2023269350 countsByYear W20232693502012 @default.
- W2023269350 countsByYear W20232693502013 @default.
- W2023269350 countsByYear W20232693502014 @default.
- W2023269350 countsByYear W20232693502015 @default.
- W2023269350 countsByYear W20232693502016 @default.
- W2023269350 countsByYear W20232693502017 @default.
- W2023269350 countsByYear W20232693502018 @default.
- W2023269350 countsByYear W20232693502019 @default.
- W2023269350 countsByYear W20232693502020 @default.
- W2023269350 countsByYear W20232693502021 @default.
- W2023269350 countsByYear W20232693502022 @default.
- W2023269350 crossrefType "journal-article" @default.
- W2023269350 hasAuthorship W2023269350A5031094606 @default.
- W2023269350 hasAuthorship W2023269350A5050821841 @default.
- W2023269350 hasAuthorship W2023269350A5055065582 @default.
- W2023269350 hasAuthorship W2023269350A5058317335 @default.
- W2023269350 hasAuthorship W2023269350A5068113028 @default.
- W2023269350 hasAuthorship W2023269350A5076715600 @default.
- W2023269350 hasConcept C121608353 @default.
- W2023269350 hasConcept C126322002 @default.
- W2023269350 hasConcept C142724271 @default.
- W2023269350 hasConcept C204232928 @default.
- W2023269350 hasConcept C2777318378 @default.
- W2023269350 hasConcept C2777407522 @default.
- W2023269350 hasConcept C2779747549 @default.
- W2023269350 hasConcept C2781182431 @default.
- W2023269350 hasConcept C2909640154 @default.
- W2023269350 hasConcept C71924100 @default.
- W2023269350 hasConcept C74864618 @default.
- W2023269350 hasConceptScore W2023269350C121608353 @default.
- W2023269350 hasConceptScore W2023269350C126322002 @default.
- W2023269350 hasConceptScore W2023269350C142724271 @default.
- W2023269350 hasConceptScore W2023269350C204232928 @default.
- W2023269350 hasConceptScore W2023269350C2777318378 @default.
- W2023269350 hasConceptScore W2023269350C2777407522 @default.
- W2023269350 hasConceptScore W2023269350C2779747549 @default.
- W2023269350 hasConceptScore W2023269350C2781182431 @default.
- W2023269350 hasConceptScore W2023269350C2909640154 @default.
- W2023269350 hasConceptScore W2023269350C71924100 @default.
- W2023269350 hasConceptScore W2023269350C74864618 @default.
- W2023269350 hasIssue "6" @default.
- W2023269350 hasLocation W20232693501 @default.
- W2023269350 hasLocation W20232693502 @default.
- W2023269350 hasOpenAccess W2023269350 @default.
- W2023269350 hasPrimaryLocation W20232693501 @default.
- W2023269350 hasRelatedWork W162258559 @default.
- W2023269350 hasRelatedWork W2069157398 @default.
- W2023269350 hasRelatedWork W2075807789 @default.
- W2023269350 hasRelatedWork W2092290021 @default.
- W2023269350 hasRelatedWork W2162029583 @default.
- W2023269350 hasRelatedWork W2276278015 @default.
- W2023269350 hasRelatedWork W2409212947 @default.
- W2023269350 hasRelatedWork W314254222 @default.
- W2023269350 hasRelatedWork W354593621 @default.
- W2023269350 hasRelatedWork W4242404509 @default.
- W2023269350 hasVolume "16" @default.
- W2023269350 isParatext "false" @default.
- W2023269350 isRetracted "false" @default.
- W2023269350 magId "2023269350" @default.
- W2023269350 workType "article" @default.